PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC

Figure 3

Effect of PLK4 on the survival prognosis of ccRCC patients. Kaplan-Meier survival analysis shows that high PLK4 expression is an unfavorable prognostic factor for survival in patients with ccRCC.